fda compounding semaglutide enforcement 2025 news September 8, 2025: launches an import alert listing safe GLP-1 manufacturers – Partnership for Safe Medicines Patients struggle as compounded GLP-1

Compounded medications are prescribed only when medically appropriate and not regularly or in inordinate amounts, per FDA guidelines under sections 503A and 503B of the FDCA

One, called glucose-dependent insulinotropic polypeptide (GIP), also helps manage blood sugar

Even imperfect outcomes from treatment attempts beat untreated obesity

Our comprehensive approach includes lifestyle interventions, such as tailored diet plans and exercise programs

After reviewing the data submitted for accelerated approval, the FDA deemed the demonstrated efficacy to be modest and not strong enough to warrant safety risks

What is a Medication Deferral